# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 24071
- **Admission ID**: 195443
- **Row ID**: 9794
- **Profile Type**: FULL

## Demographics

- **Age**: 41
- **Sex**: F
- **Date of Birth**: 2126-04-23
- **Ethnicity**: WHITE
- **Marital Status**: MARRIED
- **Religion**: CATHOLIC
- **Insurance**: Private
- **Admission Type**: EMERGENCY
- **Admission Date**: 2167-09-11 14:14:00
- **Discharge Date**: 2167-10-09 12:04:00

## Chief Complaint

vomiting

## Symptoms

- **vomiting** | onset: morning of admission date
- **feeling ill** | onset: past night
- **projectile vomiting** | onset: after eating breakfast
- **intermittent belly pain**
- **diarrhea**
- **abdominal distension (belly had gotten larger)** | onset: past few days
- **difficulty concentrating** | onset: recently
- **weight loss** | onset: since discharge on [**9-8**] | duration: 3 days
- **blood-tinged yellowish sputum with cough**
- **fatigue (tired)** | onset: recently
- **winded (mild dyspnea on exertion)** | onset: recently
- **nausea**
- **lethargy** | onset: hospital day #4
- **slurred speech** | onset: hospital day #4
- **asterixis** | onset: hospital day #4
- **fatigue**

## Medical History

1. Primary sclerosing cholangitis/auto immune hepatitis overlap, causing end stage liver disease diagnosed in [**2164**], sequelae includes massive hemorrhoids, encephalopathy and ascites; 2. Hypertrophic pulmonary osteoarthropathy; 3. Lower back disc herniation; 4. Duodenal ulcers, status post esophagogastroduodenoscopy.

## Allergies

Questionable allergy to Sulfa

## Current Medications

- **Multivitamin** | dosage: one a day
- **Vitamin D** | dosage: 400 units | frequency: q.d.
- **Calcium carbonate** | dosage: 800 mg | frequency: q.i.d.
- **Estradiol** | dosage: 600 mg | frequency: b.i.d.
- **Protonix** | dosage: 40 mg | frequency: b.i.d.
- **Aldactone** | dosage: 100 mg | frequency: q.d.
- **[**Doctor First Name 233**]-Ciel** | dosage: 20 mg | frequency: q.d.
- **Levaquin** | dosage: 500 mg | frequency: q.d.
- **Lactulose** | dosage: 30 cc | frequency: q.i.d.
- **Lasix** | dosage: 40 mg | frequency: p.o. q.d.
- **Carafate** | dosage: 1 gm | frequency: q.i.d.
- **Mycelex** | frequency: 5 times a day
- **Magnesium oxide** | dosage: 400 mg | frequency: b.i.d.

## Diagnoses

- **End stage liver disease secondary to primary sclerosing cholangitis and autoimmune hepatitis overlap with cirrhosis** | notes: Diagnosis established in 2164; sequelae include massive hemorrhoids, encephalopathy, and ascites
- Hypertension
- Hypertrophic pulmonary osteoarthropathy
- Lower back disc herniation
- **Duodenal ulcers** | notes: status post esophagogastroduodenoscopy
- **end stage liver disease** | notes: admitted directly from clinic after presenting with vomiting
- **elevated bilirubin (mostly direct)** | notes: associated with hepatic dysfunction
- **splenomegaly** | notes: on physical exam
- **abdominal distension** | notes: on physical exam
- **clubbing** | notes: on physical exam
- **hyponatremia** | notes: Developed on hospital day #2, sodium was 125
- **encephalopathy** | notes: Improved with increased Lactulose

## Treatment Options

### esophagogastroduodenoscopy

**Details**: performed the day of admission, negative for new bleed, erosion or mass

### abdominal ultrasound

**Details**: done to evaluate for portal vein thrombosis and ascites, negative

### magnetic resonance cholangiopancreatography

**Details**: no obstructive strictures, ductal distribution more affected than previously

### Medication adjustment

**Details**: Lactulose regimen increased to achieve four to six bowel movements per day

**Medications**:
- Lactulose (increased (exact dose not specified))

### Fluid restriction

**Details**: Fluid restricted to 1 to 1.5 liters for hyponatremia

### Medication hold

**Details**: All diuretics held for hyponatremia
